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ABSTRACT The ﬁrm arrest of leukocytes to the endothelium during inﬂammation is known to be mediated by endothelial
intercellular adhesion molecules (ICAMs) binding to activated integrins displayed on leukocyte surface. Selectin-ligand
interactions, which mediate rolling, are believed to be important for facilitating ﬁrm adhesion, either by activating integrins or by
facilitating the transition to ﬁrm adhesion by making it easier for integrins to bind. Although leukocytes employ two distinct
adhesion molecules that mediate different states of adhesion, the fundamental biophysical mechanisms by which two pairs of
adhesion molecules facilitate cell adhesion is not well understood. In this work, we attempt to understand the interaction
between two molecular systems using a cell-free system in which polystyrene microspheres functionalized with the selectin
ligand, sialyl LewisX (sLeX), and an antibody against ICAM-1, aICAM-1, are perfused over P-selectin/ICAM-1 coated surfaces in
a parallel plate ﬂow chamber. Separately, sLeX/P-selectin interactions support rolling and aICAM-1/ICAM-1 interactions mediate
ﬁrm adhesion. Our results show that sLeX/aICAM-1 microspheres will ﬁrmly adhere to P-selectin/ICAM-1 coated surfaces, and
that the extent of ﬁrm adhesion of microspheres is dependent on wall shear stress within the ﬂow chamber, sLeX/aICAM-1
microsphere site density, and P-selectin/ICAM-1 surface density ratio. We show that P-selectin’s interaction with sLeX
mechanistically facilitates ﬁrm adhesion mediated by antibody binding to ICAM-1: the extent of ﬁrm adhesion for the same
concentration of aICAM-1/ICAM-1 interaction is greater when sLeX/P-selectin interactions are present. aICAM-1/ICAM-1
interactions also stabilize rolling by increasing pause times and decreasing average rolling velocities. Although aICAM-1 is
a surrogate for b2-integrin, the kinetics of association between aICAM-1 and ICAM-1 is within a factor of 1.5 of activated integrin
binding ICAM-1, suggesting the ﬁndings from this model system may be insightful to the mechanism of leukocyte ﬁrm adhesion.
In particular, these experimental results show how two molecule systems can interact to produce an effect not achievable by
either system alone, a fundamental mechanism that may pervade leukocyte adhesion biology.
INTRODUCTION
Adhesion of leukocytes to vascular wall in response to
inﬂammation is an important, well-studied phenomenon that
follows a multistep adhesion cascade, comprised of an initial
tethering step, ﬁrm arrest, and transendothelial migration of
leukocytes. Initial leukocyte (neutrophil) adhesion, referred
to as rolling, is mediated by a class of adhesive molecules
called selectins (L-, P-, and E-selectin). These molecules
initiate rolling by binding to their carbohydrate counter-
receptors on leukocyte surface (P- and E-selectin) or the
endothelium (L-selectin) (Lawrence and Springer, 1991;
Springer, 1994). After this initial tethering, leukocytes ﬁrmly
adhere to the endothelium via the binding of activated
b2-integrins to intercellular adhesion molecules (ICAMs)
expressed on endothelial surface (Ebnet and Vestweber,
1999). To date, two independent mechanisms have been
proposed for integrin activation. One mechanism suggests
integrin activation results from chemotactic stimulation of
leukocytes (Springer, 1994) whereas another suggests
selectin ligation leads to integrin activation (Evangelista
et al., 1999; Simon et al., 2000). Work done by Blanks and
co-workers with Chinese hamster ovary cells expressing
P-selectin suggests that P-selectin glycoprotein ligand-1
(PSGL-1) expressed on neutrophils binding to P-selectin
results in the activation of b2-integrin, thereby facilitating
neutrophil adhesion to ICAM-1 expressing cells (Blanks
et al., 1998). Furthermore, Gopalan et al. showed that cross-
linking L-selectin activates the integrin, LFA-1, that binds to
ICAM-1 (Gopalan et al., 1997).
Regardless of the mechanism of integrin activation, what is
clear is that rolling is essential for ﬁrm arrest and eventual
transmigration of leukocytes to inﬂamed tissues. The question
is, is there any role for selectin-mediated rolling in facilitating
the transition to ﬁrm adhesion beyond the activation of inte-
grins? More generally, the paradigm of two molecules, each
with different physical chemistry and capable of supporting
different dynamics states of adhesion, acting in concert, is
ubiquitous in adhesion biology, but the precise interplay
between two different molecule systems is not understood.
Therefore, the goal of this article is to systematically construct
an experimental system that will allow us to understand the
fundamental biophysical interplay between two molecules,
motivated by leukocyte adhesion biology, and thus suggest
a mechanism by which selectins may facilitate the transition
to ﬁrm adhesion via integrins.
To do this, we will use cell-free systems in which micro-
spheres coated with two ligands, sialyl LewisX (sLex) and an
antibody against ICAM-1 (BBIG-I1), are allowed to interact
with selectin/ICAM-1 surfaces under ﬂow, mimicking the
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weak ligand-strong ligand chemistry present in leukocyte
adhesion. Speciﬁcally, sLeX/P-selectin interactions have
been shown to support rolling adhesion (Rodgers et al.,
2000), and here we show that binding between anti-ICAM-I
(aICAM-1) and ICAM-1 mediates ﬁrm binding. Cell-free
systems such as this have successfully been used to elucidate
the physical chemistry of selectin-mediated rolling (Brunk
and Hammer, 1997; Greenberg et al., 2000; Rodgers et al.,
2000), but cell-free systems have not been used to
understand the transition from rolling to ﬁrm adhesion.
Fig. 1 shows a schematic illustration of the cell-free system
used in this work. This system is ideal to understand the role
of wall shear stress, the ratio of P-selectin/ICAM-1 surface
density ratio, and the ratio of sLeX/aICAM-1 density in the
transition from rolling to ﬁrm adhesion in a two-receptor
system because in a cell-free system we can adjust the
properties of the system systematically in ways that are not
easily achieved in cell systems. Our results show that at
several intermediate sLeX/aICAM-1 ratios, selectin-ligand
interactions are critical for optimal ICAM-1-mediated
ﬁrm adhesion. We ﬁnd that the amount of ﬁrmly adhering
microspheres is dependent on wall shear stress, P-selectin/
ICAM-1 surface density ratio, and sLeX/aICAM-1 micro-
sphere site density ratio. We show that removing sialyic acid
from sLeX, which renders the carbohydrate inactive as
a rolling ligand, greatly reduces the extent of ﬁrm adhesion.
In addition, we show that ICAM-1 interactions stabilize
rolling, by decreasing the average rolling velocity and
increasing the pause times during microsphere rolling. The
suggestion that the results of our model system are indicative
of mechanisms that may be at play in leukocyte adhesion is
enhanced by our ﬁnding that the on-rate for aICAM-1
binding to ICAM-1 is within a factor of 1.5 of that between
activated b2-integrin and ICAM-1. Overall, we believe this
article identiﬁes a mechanistic role of selectins in facilitating
the transition to ﬁrm adhesion in leukocytes.
MATERIALS AND METHODS
Adhesion molecules and antibodies
Soluble, recombinant P-selectin (sP) containing the entire extracellular
domain of the molecule was a generous gift from Dr. Raymond T.
Camphausen, Wyeth (Cambridge, MA) (Rodgers et al., 2000). Biotinylated,
multivalent sialyl LewisX and LewisX (LeX) carbohydrate were purchased
from Glycotech (Rockville, MD). Recombinant human ICAM-1/Fc chimera
(human IgG1), biotinylated anti-ICAM-1 monoclonal antibody (mAb)
BBIG-I1, FITC-labeled anti-P-selectin mAb 9E1, and anti-ICAM-1 mAb
BBIG-I1 were purchased from R & D systems (Minneapolis, MN). Anti-
sLeX mAb HECA-452, FITC-labeled anti-rat IgM, and FITC-labeled anti-
mouse IgG1 were purchased from Pharmingen (San Diego, CA).
Substrate preparation
P-selectin/ICAM-1 surfaces were prepared by a method similar to that de-
scribed in previous publication (Rodgers et al., 2000). In this method, double
well, rectangular, ﬂexiperm gaskets (Sigma, St. Louis, MO) were placed on
microscope slides cut from bacteriological polystyrene dishes. The surface
enclosed by one of the two wells was incubated overnight with 374 mL of
2.5, 5, or 10 mg/mL ICAM-1 in binding buffer (0.1 M NaHCO3) and the
other well with binding buffer. After ICAM-1 incubation, ICAM-1 coated
surfaces were washed twice with 2 mL binding buffer, after which the double
well gaskets were replaced with single well, rectangular gaskets. The
surfaces enclosed by the single well gaskets were coated with 800 mL of 12,
10, or 4 mg/mL P-selectin in binding buffer for a period of 2 h. After coating
with P-selectin, the surfaces were incubated with 2 mL of a heat-denatured
solution of 2% bovine serum albumin (BSA) in Dulbecco’s phosphate
buffered saline (DPBS) (pH¼ 7.4) for a minimum of 30 min, and before use
in laminar ﬂow assays, slides were incubated for 2 min with 1% Tween 20 in
DPBS. Control surfaces were prepared using the BSA blocking step only.
P-selectin/ICAM-1 site density determination
For site density determination, eight-well, rectangular, ﬂexiperm gaskets
were placed on polystyrene slides. ICAM-1 was incubated overnight at one
concentration, followed by P-selectin incubation for 2 h as described in
the previous section. After protein incubation, wells were coated with 2%
denatured BSA solution. BSA-blocked, P-selectin/ICAM-1 surfaces were
then incubated with a saturating concentration of FITC-labeled aICAM-1
mAb (BBIG-I1) or anti-P-selectin mAb (9E1). Fluorescence intensity was
obtained using FeliX software (Photon Technologies, Severna Park, MD)
and a Nikon Diaphot inverted microscope (Melville, NY) equipped with
a FITC cube and connected to a photomultiplier tube (Photoscan, Nikon,
Tokyo, Japan). P-selectin/ICAM-1 site density (molecules/mm2) was
obtained using calibration curves generated by measuring the ﬂuorescence
of known concentrations of anti-P-selectin and aICAM-1 mAbs as
previously described (Brunk and Hammer, 1997).
Microsphere preparation
Biotinylated sLeX, a 30-kD carbohydrate probe that has been described
in previous publications (Brunk and Hammer, 1997; Greenberg et al.,
2000; Rodgers et al., 2000), and biotinylated aICAM-1 mAb were diluted to
5 mg/mL in DPBS1, (DPBS, 1% BSA, pH¼ 7.4). These two solutions were
thenmixed at ratios between 0% and 100% sLeX. A total of 106 SuperAvidin-
FIGURE 1 A schematic of a cell-free system used to understand the
physical chemistry of ICAM-1 mediated leukocyte adhesion. Plastic surface
with immobilized P-selectin and ICAM-1 represents the endothelial wall,
and polystyrene microspheres coated with sLeX and anti-ICAM-1 mAb are
used as model leukocytes.
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coated beads (;10 mm) were simultaneously coated with sLeX and anti-
ICAM-1 by incubating the beads with 100 mL solution containing different
ratiosofbiotinylatedsLeXandaICAM-1mAbfor1hat roomtemperature,with
continuous vortexing. Beads were then washed three times in DPBS1 and
resuspended in 2 mLDPBS1 until ready for use in adhesion experiments.
Carbohydrate and antibody site
density determination
For sLeX site density determination, 105 aICAM-1/sLeX-coated beads were
incubated with 100 mL of 30 mg/ml rat-IgM anti-human Cutaneous
Lymphocyte Antigen (CLA) reactive to sLeX (HECA-452) for 1 h. Beads
were then washed two times with DPBS1 and incubated for 1 h with 100 mL
of 30 mg/ml FITC-labeled anti-rat IgM mAb. Fluorescence intensities were
measured using ﬂow cytometry, and sLeX site densities were estimated as
described previously (Brunk and Hammer, 1997). Fluorescence shifts were
converted to site densities using a calibration curve relating mean peak
ﬂuorescence of Quantum 26 calibration beads (Bangs Laboratories, Fishers,
IN) to their molecules of equivalent soluble ﬂuorochrome (MESF). Using
the molecules of equivalent soluble ﬂuorochrome/protein ratio of the FITC-
conjugated secondary antibody and assuming a 1:1 relationship between
sLeX, the primary and secondary antibody, the number of surface-bound
molecules was determined. For anti-ICAM-1 density determination, 105
aICAM-1/sLeX-coated beads were incubated with 100 mL of 30 mg/ml
FITC-conjugated anti-mouse IgG1 monoclonal antibody reactive to the
mouse IgG1 residue on the biotinylated aICAM-1 mAb. Assuming a 1:1
binding ratio between aICAM-1 and the ﬂuorescence antibody, aICAM-1
site density was calculated similar to that of sLeX.
Determination of binding constant of
anti-ICAM-1 mAb (BBIG-I1) to ICAM-1
Binding kinetics of anti-ICAM-1 mAb was measured on a BIAcore 1000
instrument (BIAcore, Piscataway, NJ). StreptAvidin (SA)-chips were
purchased from BIAcore and stored at 48C before use. To begin measure-
ment, a SA-chip was loaded into the BIAcore 1000, after which the surface
was exposed to three 1-min injections of conditioning buffer (10 mM NaCl
in 50 mM NaOH) at 30 ml/min. After conditioning, the chip was washed
with HBS-EP buffer (10 mM HEPES, pH 7.4, 0.15 M NaCl, 3 mM EDTA,
0.005% Tween 20) for 5 min at 20 ml/min to block nonspeciﬁc adhesion.
Biotinylated anti-ICAM-1, BBIG-I1, was immobilized onto the surface by
ﬂowing 16 mg/ml antibody in HBS-EP buffer over the chip at 5 ml/min until
saturation (;1700 response units). After the adsorption of aICAM-1, the
surface was washed with HBS-EP for ;15 min at 20 ml/min to remove
excess antibody. Binding constants for the interactions between aICAM-1
and ICAM-1 were obtained by injecting various concentrations of ICAM-1
in HBS-EP buffer over the anti-ICAM-1 surface at 20 ml/min for 3 min, after
which HBS-EP buffer is allowed to ﬂow over the surface for 3 min to access
the rate of ICAM-1 detachment from the surface. Fig. 2 shows how the
response units (RU) vary as a function of time for the association and
dissociation of ICAM-1 to antibody-immobilized surface. ka and kd, the on-
rate and off-rate of aICAM-1 binding to ICAM-1, were determined by ﬁtting
a kinetic expression given by Eq. 1 to this binding data using the
BIAevaluation software (BIAcore) as previously described by Labadia and
co-workers (Labadia et al., 1998).
R ¼ ka½ICAM  1Rmax
ka½ICAM  11 kd
 
1 R0  ka½ICAM  1Rmax
ka½ICAM  11 kd
 
3 eðka½ICAM11kdÞðttoÞ1RI ð1Þ
This expression is applied to all kinetic data, estimating the parameters ka, kd,
and Rmax. In this expression, R0 is the refractive index before the injection of
ICAM-1, R is the refractive index as a function of time after injection of
ICAM-1, RI is the bulk refractive index contribution, and Rmax is the
maximal value of R observed when all the immobilized aICAM-1 is
saturated with ICAM-1. Surface regeneration (removal of bound ICAM-1)
was achieved by exposing the surface to a 1-min injection of 10 mM HCl at
20 ml/min. Control experiments where different concentrations of ICAM-1
were perfused over a blank SA-chip registered no response above the base
level (data not shown).
Laminar ﬂow assay
A straight-channel, parallel-plate ﬂow chamber was used for laminar ﬂow
assays. The straight-channel template was cut from 0.01-inch-thick
Duralastic sheeting (Allied Biomedical, Goose Creek, SC). For each ﬂow
experiment, the template was placed over P-selectin/ICAM-1 coated poly-
styrene slide. The template and slide were placed in the bottom well of the
ﬂow chamber and the top secured with nuts and bolts. Flow chamber exp-
erimental setup was as previously described, where the assembled chamber
was mounted on the stage of a Nikon Diaphot inverted microscope with
phase-contrast optics (Rodgers et al., 2000; Eniola et al., 2002). sLeX/
aICAM-1 beads were placed in a test tube and connected to the ﬂow
chamber using rubber tubing. Flow of bead solution over P-selectin/ICAM-1
surfaces was initiated with an infusion/withdrawal syringe pump (Harvard
Apparatus, South Natick, MA). Experiments were recorded using a Cohu
black and white CCD camera (Cohu, San Diego, CA) and Sony SVO-
9500MD S-VHS recorder (Sony Medical Systems, Montvale, NJ).
Recognizing that the rate of transport of microspheres to substrate surface
is likely a function of ﬂow rate as described by Munn and co-workers (Munn
et al., 1994), the start time for data collection was adjusted according to the
time it takes microspheres to enter the chamber at each ﬂow rate studied.
Rolling and ﬁrm binding data were collected 3 min after microspheres enter
the chamber for all ﬂow rates explored. Furthermore, to account for the
variation in ﬂuxes along the chamber length, data were collected at a constant
position along the chamber for all experiments. For each experiment, wall
shear stress (tw) was calculated according to
tw ¼ 6mQ
h
2
w
; (2)
where m is the ﬂuid viscosity, Q is the volumetric ﬂow rate, h is the channel
height, and w is the channel width.
FIGURE 2 Plot of response unit (RU) versus time showing the
association and dissociation of ICAM-1 to immobilized anti-ICAM-1 at
different concentrations of ICAM-1. Arrows indicated points of injection of
speciﬁc reagents.
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Data analysis
Rolling and bound ﬂux of interacting beads were obtained manually by
counting the number of rolling and bound beads in the window of view (0.32
mm2) over a period of 1 min. Instantaneous and average rolling velocities
were obtained through digital image analysis of video recordings of adhesion
experiments, using LabView software (National Instrument, Austin, TX).
Instantaneous rolling velocity data were obtained every 1/10 of a second, and
the average rolling velocities were obtained by taking the mean velocity of at
least 10 particles continuously rolling for 3 s or longer (Rodgers et al., 2000).
The average fraction of time paused by beads was obtained by taking the
mean fraction of pause time of at least ﬁve particles over a period of at least
10 s. Error bars were plotted using SE calculation unless otherwise noted.
Differences in the level of ﬁrm adhesion between microspheres with
different ratios of sLeX/aICAM-1 were examined using the two-tailed
Student’s t-test. A value of p\0.05 was considered statistically signiﬁcant.
RESULTS
Characterization of microspheres and
polystyrene surfaces
Microsphere sLeX/aICAM-1 site densities were determined
by ﬂow cytometry. Fig. 3 shows the ﬂuorescence histograms
obtained for sLeX and aICAM-1 labeling on the bead sur-
face, and the resulting plot of sLeX microsphere site density
as a function of the coating ratio of sLeX used in solution.
Rightward shift in ﬂuorescence intensity of sample beads
from the control shown in Fig. 3, A and B, conﬁrms the
presence of both sLeX and anti-ICAM-1 on microsphere
surface, and Fig. 3 C suggests a linear relationship between
the coating ratio and site density ratio of sLeX/aICAM-1. The
ﬂuorescence intensities were related to molecular density
using ﬂuorescent calibration beads. The site densities of
sLeX and aICAM-1 on microsphere surface are listed in
Table 1. The total amount of aICAM-1 on microspheres
coated with solutions containing 50:50 and 25:75 sLeX/
aICAM-1, 500 and 1057 sites/mm2 (based on a microsphere
surface area of 314 mm2), respectively, is within the range of
site densities of b2-integrins on activated neutrophils, 515–
1400 sites/mm2 (based on an apparent surface area of 227
mm2; Shao et al., 1998), that has been reported in literature
(Thiel et al., 1997). Similarly, the amount of aICAM-1 on
beads coated with 75:25 sLeX/aICAM-1, 168 sites/mm2, is
slightly lower than, but of the same order as, the amount of
b2-integrins, ;300 sites/mm
2, on resting neutrophils (Thiel
et al., 1997; Edwards et al., 2000).
P-selectin/ICAM-1 density ratios on polystyrene sur-
faces were determined by surface ﬂuorescence imaging. A
50:50 P-selectin/ICAM-1 ratio was obtained when slides
were coated with 5 mg/ml ICAM-1 followed by 10 mg/ml
P-selectin. Similarly, slides coated with 2.5 mg/ml ICAM-1
and 12.5 mg/ml P-selectin yielded an 80:20 P-selectin/
ICAM-1 surface ratio, and a 30:70 ratio was obtained when
slides were coated with 10 mg/ml and 4 mg/ml ICAM-1 and
P-selectin, respectively. The average total substrate site
density of surfaces used in ﬂow experiments was 4086 35.5
sites/mm2.
Binding kinetics of aICAM-1 binding to ICAM-1
The binding kinetics of anti-ICAM-1 mAb, BBIG-I1, to
ICAM-1 was measured on BIACORE 1000. Fig. 4 shows the
data (symbols) and global analysis ﬁtted (line) curves of the
association and dissociation interactions between antibody
and ICAM-1. The on-rate (kon) and off-rate (koff) for the
antibody/ICAM-1 interactions obtained using the BIAeval-
uation software as described in the Materials and Methods
section, were 156,000 (646,000) M1s1 and 1.13 (60.11)
3 104 s1 respectively (where the numbers in parentheses
represent SE for n ¼ 5).
Rolling and ﬁrm adhesion of microspheres
Flow adhesion assays with polystyrene microspheres coated
with different ratios of sLeX/aICAM-1 show these beads can
roll and ﬁrmly adhere to P-selectin/ICAM-1-coated surfaces.
Fig. 5 shows the binding ﬂux of 50:50 sLeX/aICAM-1 beads
over 50:50 P-selectin/ICAM-1 and P-selectin surfaces at 131
s1. Under these conditions, beads bind ﬁrmly to P-selectin/
ICAM-1 surfaces; however, these same beads showed an
insigniﬁcant level of ﬁrm adhesion on surfaces coated with
P-selectin only. Furthermore, no signiﬁcant ﬁrm adhesion
was recorded when sLeX-coated (no aICAM-1) beads were
perfused over the 50:50 P-selectin/ICAM-1 surfaces (Fig. 4).
Thus, ﬁrm adhesion requires the presence of anti-ICAM-1 on
the bead surface, and ICAM-1 on the substrate.
Dynamics of microsphere adhesion depends
on densities of two molecules
Fig. 6, A and B, illustrates how binding ﬂux for two-molecule
microspheres depends on the amount of anti-ICAM-1 on the
bead surface and wall shear stress on both P-selectin and
50:50 P-selectin/ICAM-1 surfaces, respectively. Fig. 6 A
shows that the rolling ﬂux of sLeX/aICAM-1 microspheres
on P-selectin decreases with increasing wall shear stress.
This ﬁgure also shows that rolling ﬂux on P-selectin decre-
ases as the ratio of aICAM-1 to sLeX on the bead surface
increases.
Fig. 6 B shows how the level of ﬁrm binding (left
ordinate) and the amount of aICAM-1 (right ordinate) vary
with the ratio of sLeX/aICAM-1 on the bead. This ﬁgure
shows that ﬁrm binding of microspheres on an P-selectin/
ICAM-1 surface decreases with increasing wall shear stress.
When there is little or no aICAM-1 on the bead, there is no
ﬁrm adhesion. Furthermore, at any wall shear stress, the
number of beads ﬁrmly bound to P-selectin/ICAM-1 surface
increases as the relative amount of aICAM-1 to sLeX on the
bead surface increases up to a maximum, and then plateaus
or decreases (Fig. 6 B). Interestingly, there is about a 5-fold
increase in the number of ﬁrmly adherent beads as the ratio
of aICAM-1 to sLeX on microsphere increases from 25%
to 50% aICAM-1. This observation suggests that sLeX/
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P-selectin interactions might be augmenting microsphere
ﬁrm binding to P-selectin/ICAM-1 since there is only a
;3-fold increase in the amount of aICAM-1 on microsphere
surface as the aICAM-1 to sLeX ratio increases from 25% to
50% (seeTable 1 and right ordinate onFig. 6B). Furthermore,
at most shear rates studied, there seems to be no statistical
difference in the ﬁrm adhesion (p-values were between 0.25
and 0.27) on P-selectin/ICAM-1 surfaces as the ratio of
FIGURE 3 Flow cytometry data for sLeX/anti-ICAM-1
microspheres. (A and B) Fluorescence histograms for
SuperAvidin microspheres incubated with 5 mg/ml
solutions containing 0%, 25%, 50%, 75%, and 100%
sLeX. (A) Microspheres with HECA-452 binding to sLeX
epitopes and FITC labeled anti-rat IgMmAb binding to the
rat IgM residue on HECA-452. Microspheres incubated
with solution containing 0% sLeX (100% anti-ICAM-1)
were used as control. (B) Microspheres with FITC-labeled
anti-mouse IgG1 mAb binding to the mouse IgG1 residue
on anti-ICAM-1 mAb. (C) sLeX microsphere site density
ratio as a function of sLeX coating ratio. Error bars are 95%
conﬁdence intervals.
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aICAM-1 to sLeX on microsphere increases from 50% to
100% aICAM-1, although there is a signiﬁcant increase in the
amount of aICAM-1 on microsphere surface (from 500 to
2282 sites/mm2; see Table 1 and right abscissa in Fig. 6 B). In
other words, similar levels of ﬁrm adhesion are observed with
microspheres with signiﬁcantly different amounts of aICAM-
1 present on their surface. This strongly suggests that at 50%
and75%aICAM-1 to sLeXmicrosphere site density ratios, the
presence of rolling interactions enhances the ﬁrm adhesion of
microspheres, since the same level of ﬁrm adhesion is seen
with fewer aICAM-1 molecules. Perfusion of sLeX/aICAM-1
beads over P-selectin surfaces shows an insigniﬁcant level
of ﬁrm adhesion at all microsphere site density ratios, which
suggests there is no interaction between aICAM-1 mAb and
P-selectin, and that P-selectin interactions do not support ﬁrm
binding (Fig. 6 A).
Correspondingly, one can examine the rolling ﬂux under
the same conditions. Fig. 6 C compares the rolling and
binding ﬂux of sLeX/aICAM-1 beads on a 50:50 P-selectin/
ICAM-1 surface. This plot shows that rolling ﬂux pro-
gressively decreases as the ratio of sLeX to aICAM-1 de-
creases. Clearly, the absence of sLeX (for beads with 100%
aICAM-1) prevents rolling, i.e., anti-ICAM-1 does not
support rolling interactions by itself as suggested by its high
afﬁnity binding to ICAM-1. Furthermore, the large drop
(80% decrease) in the rolling ﬂux of beads over P-selectin/
ICAM-1 surfaces seen as aICAM-1 ratio increases from 25%
to 50% reﬂects the transition from rolling to ﬁrm adhesion
of sLeX/aICAM-1 coated microspheres, since such a sharp
decrease is not observed with beads interacting with
P-selectin only (17% decrease) (Fig. 6 A). Fig. 6 C also il-
lustrates that the total accumulation of beads on a surface
is constant or decreases slightly for all aICAM-1 sLeX
combinations, except for beads without any sLeX (100%
aICAM-1). This data suggest some minimal presence of
sLeX is necessary for maximal accumulation, but that
aICAM-1 is capable of some extent of accumulation in the
absence of sLeX.
We also examined the inﬂuence of the P-selectin/ICAM-1
surface ratio on the extent of ﬁrm adhesion. Microspheres
TABLE 1 Molecular site densities of sLeX and anti-ICAM-1
on microsphere surface
Coating concentration
Molecule site density (sites/mm2)
(% aICAM-1) sLeX Anti-ICAM-1
0 1167 0
25 1019 168
50 796 500
75 444 1047
100 0 2282
Microsphere surface area ¼ 314 mm2.
FIGURE 4 Determination of the kinetic rate constant for the interactions
between immobilized anti-ICAM-1 mAb and ICAM-1. Symbols are
experimental data obtain from the (A) association and (B) dissociation of
ICAM-1 to immobilized anti-ICAM-1, and the lines represents ﬁtted values
predicted by Eq. 1. Nonlinear regression global analysis converged to ka and
kd values of 156,000 (646,000) M
1s1 and 1.13 (60.11) 3 104 s1,
respectively (numbers in parentheses represent SE for n ¼ 5).
FIGURE 5 Firm attachment ﬂux of sLeX/anti-ICAM-1 9.95-mm micro-
spheres with 50% (n) and 100% () sLeX site density ratio interacting with
50:50 P-selectin/ICAM-1 (204 6 17.8 sites/mm2 P-selectin) and P-selectin
surface (363 6 5.5 sites/mm2) at 131 s1. Abscissa labels describe surface
coating.
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with different ratios of sLeX/aICAM-1 were perfused over
surfaces with 30:70, 50:50, 80:20, and 100:0 P-selectin/
ICAM-1 site density ratios. Fig. 7 A illustrates how the ﬁrm
binding of microspheres changes on these P-selectin/ICAM-
1 surfaces. When the beads with lower sLeX/aICAM-1 ratios
(aICAM-1[50%) interact with P-selectin/ICAM-1 surfaces,
ﬁrm adhesion increased as the amount of ICAM-1 on the
surface increased. However, binding of beads with aICAM-1
ratio\50% (higher sLeX/aICAM-1 ratios) was limited; in-
creasing ICAM-1 concentration did not always lead to an
increase in adhesion, suggesting that the extent of adhesion is
not solely due to ICAM-1 interactions. Fig. 7 B compares the
rolling and binding ﬂux of 50% sLeX/aICAM-1 coated beads
on surfaces with different ratios of P-selectin/ICAM-1. As
the molecular surface density ratio increases from 0% to 50%
ICAM-1, we see a correlation between the decrease in rolling
ﬂux and the increase in ﬁrm binding ﬂux, suggesting beads
that had been rolling on P-selectin were now ﬁrmly bound
via ICAM-1. Also, the maximum in ﬁrm binding occurs not
at the highest ICAM-1 surface density, but rather when there
is a 70:30 ratio of ICAM-1 to P-selectin on the surface.
Therefore, ﬁrm adhesion is most likely when there is a rolling
ligand in combination with a ﬁrm adhesion ligand.
FIGURE 6 Rolling and binding ﬂux of 10.2-mm sLeX/anti-ICAM-1
microspheres. (A) Rolling ﬂux on a P-selectin surface and (B) binding ﬂux
on 50:50 selectin/ICAM-1 surface as a function of anti-ICAM-1 micro-
sphere coating ratio at shear rates of 125 (r), 152 (n), and 208 s1(d). (C)
Comparison of binding (n) and rolling (m) ﬂux on 50:50 selectin/ICAM-1
surface as a function of anti-ICAM-1 microsphere coating ratio at a shear
rate of 152 s1. Circles represent the average of the total accumulation of
microspheres at 100%–25% sLeX/aICAM-1 coating ratios. Data averaged
over three experiments and four different positions in the ﬂow chamber.
FIGURE 7 (A) Binding ﬂux of 9.95-mm sLeX/anti-ICAM-1 microspheres
at 131 s1 as a function of anti-ICAM-1 microsphere coating ratio on 100%
(d), 80% (*), 50% (e), and 30% (n) P-selectin surfaces. Average total
P-selectin/ICAM-1 site density was 408 6 35.5 sites/mm2. (B) Comparison
of binding (n) and rolling (r) ﬂux of 9.95 mm, 50:50 sLeX/aICAM-1 beads
as a function of substrate molecular site density ratio of ICAM-1 to
P-selectinat a shear rate of 131 s1.
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P-selectin-ligand (sLeX) interactions (rolling)
facilitate ICAM-1-mediated ﬁrm binding
Data displayed in Figs. 6 and 7 suggest that ﬁrm binding of
two-molecule beads can be facilitated by rolling. To dem-
onstrate this biophysical principle yet another way, mi-
crospheres were coated with anti-ICAM-1 and LeX, a
carbohydrate structure similar to sLeX but devoid of sialic
acid, and not capable of mediating rolling on selectins
(Rodgers et al., 2000). Lex/aICAM-1 microspheres at any
concentration of molecules do not roll when perfused over
P-selectin or P-selectin/ICAM-1 surfaces (data not shown).
Fig. 8 compares binding of Lex/aICAM-1 beads on
P-selectin/ICAM-1 surfaces to that of sLeX/aICAM-1 beads
on the same surface. Since sLeX can support rolling and LeX
cannot, this comparison clearly indicates the contribution of
rolling interactions to the extent of ﬁrm adhesion. Beads
coated with greater than 50:50 LeX/aICAM-1 did not bind to
P-selectin/ICAM-1 surfaces because they do not have eno-
ugh aICAM-1 to support ﬁrm adhesion themselves, and LeX
does not support rolling. When beads are coated with 50%
aICAM-1, replacing sLeX with LeX decreases ﬁrm binding at
all P-selectin concentrations (Fig. 8). Speciﬁcally, replacing
LeX with sLeX at 50:50 ratios of carbohydrate to aICAM-1
leads to a 12-, 9-, and 4-fold increase in the extent of ﬁrm
adhesion on 80:20, 50:50, and 30:70 P-selectin/ICAM-1
surfaces, respectively. Examination of the results from 25%
to 75% aICAM-1 on all P-selectin/ICAM-1 densities
indicate rolling greatly facilitates the transition to ﬁrm
adhesion of dually coated microspheres. As the density of
ICAM-1 decreases on the substrate surface (higher values of
P-selectin/ICAM-1), the critical need for sLeX in facilitating
ﬁrm adhesion increases, and higher aICAM-1 densities are
required to compensate for the decrease in ICAM-1 density.
For example, for 80:20 P-selectin/ICAM-1 surfaces, the
maximal increase in ﬁrm binding between sLeX/aICAM-1
and LeX/aICAM-1 beads is at 75% aICAM-1. Overall,
selectin interactions aid the transition to ﬁrm adhesion at
intermediate aICAM-1/sLeX densities, suggesting the two
molecules work synergistically to increase adhesion.
ICAM-1-antibody interactions slow rolling
In addition to measuring the binding ﬂuxes of ﬁrmly bound
sLeX/aICAM-1 beads, rolling velocities of microspheres on
P-selectin and P-selectin/ICAM-1 surfaces were measured.
Fig. 9, top compares the average rolling velocity of sLeX/
aICAM-1 coated beads on P-selectin and P-selectin/ICAM-1
surfaces. Average microsphere rolling velocity on P-selectin/
ICAM-1 surfaces decreases with decreasing sLeX/aICAM-1
bead density ratio (increasing %aICAM-1). This observation
is in contrast to what is seen with the same microspheres
rolling on P-selectin surfaces (see Fig. 9, top) where, because
sLeX density is decreasing, rolling velocity increases. This
shows that microsphere rolling on P-selectin/ICAM-1 sur-
faces is stabilized by ICAM-1-antibody bonds between
microsphere and surface, and that some degree of ICAM-1
binding can be tolerated and support rolling adhesion. In
addition, Fig. 9, bottom, which compares microsphere rolling
velocity on surfaces with different ratios of P-selectin/ICAM-
1 (30:70, 50:50, and 80:20), shows an interesting transition
between P-selectin-controlled and ICAM-controlled regimes.
When the microspheres are predominately coated with sLeX
(low aICAM-1), average rolling velocity decreases when
P-selectin is added to the surface (i.e., increasing P-selectin
surface ratio). In this regime, the dynamics of adhesion are
controlled by P-selectin interactions. However, when the
beads are predominately (but not exclusively) coated with
a-ICAM-1, increasing P-selectin on the surface can lead to an
increase in the rolling velocity. At one surface ratio of P-
FIGURE 8 Comparison of binding ﬂuxes of 9.95-mm LeX/anti-ICAM-1
and sLeX/anti-ICAM-1 beads on (top) 30:70, (middle) 50:50, and (bottom)
80:20 P-selectin/ICAM-1 surfaces at a shear rate of 131 s1.
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selectin/ICAM-1 (80:20), the net effect of these counter-
opposing forces is that rolling velocity is independent of the
relative amount of ligands on the bead surface. These results
suggest a two-molecule system can illustrate interesting
dynamic control mechanisms to maintain constant levels of
rolling adhesion over wide range of surface densities.
To further understand the rolling interactions of the two-
molecule microspheres on P-selectin/ICAM-1 surfaces, in-
stantaneous rolling velocities of microspheres on P-selectin
and P-selectin/ICAM-1 surfaces were examined. Fig. 10, A
and B, shows the instantaneous velocity traces as a function
of time for 50% aICAM-1 beads on P-selectin (363 6 5.5
sites/mm2) and 50:50 P-selectin/ICAM-1 (;204 6 17.8
sites/mm2 P-selectin). As shown in these traces, sLeX/
aICAM-1 beads interacting with P-selectin/ICAM-1 surfaces
displayed slower rolling velocity when compared to beads
rolling on pure P-selectin surface, though the selectin site
density was lower on the P-selectin/ICAM-1 surface. Fur-
thermore, these 50% aICAM-1 beads displayed long dura-
tion of pauses (periods of zero instantaneous velocity) when
interacting with P-selectin/ICAM-1 surface, suggesting
a gradual transition from rolling to ﬁrm adhesion. These
periods of pausing are due to ICAM-1/aICAM-1 interac-
tions, since similar beads showed short pauses or no pauses
when rolling on surfaces without ICAM-1, as shown in Fig.
10 A. Fig. 10 C, showing a plot of average fraction of time
paused by sLeX/aICAM-1 beads as a function of aICAM-1
FIGURE 9 Rolling velocity of 9.95-mm sLeX/anti-ICAM-1 microspheres
on P-selectin and P-selectin/ICAM-1 surfaces. (Top) Comparison of rolling
velocity on P-selectin (r) and 30:70 P-selectin/ICAM-1 (e) surfaces as
function of anti-ICAM-1 microsphere coating ratio at a shear rate of 131 s1.
(Bottom) Comparison of rolling velocity on 30:70 (n), 50:50 (}), and 80:20
(*) P-selectin/anti-ICAM-1 surfaces as function of anti-ICAM-1 micro-
sphere coating ratio at a shear rate of 131 s1.
FIGURE 10 Instantaneous velocity traces of 10.2-mm microspheres
coated with 50% sLeX beads on a (A) P-selectin (363 6 5.5 sites/mm2)
surface and (B) 50:50 P-selectin/ICAM-1 at 125 s1. Instantaneous
velocities were taken every 1/10 s. (C) Average fraction of time paused
by sLeX/anti-ICAM-1 beads on a 50:50 P-selectin/ICAM-1 surface as
a function of anti-ICAM-1 coating ratio (aICAM-1 bead site density) over
a period of 10 s at 125 s1.
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bead coating ratio, shows that the fraction of time during
which beads are paused increases as the ratio of aICAM-1 to
sLeX increases from 0% to 100%; where at a 100% aICAM-1
ratio, no beads are rolling. This plot illustrates that the
periods of pausing displayed by sLeX/aICAM-1 beads on P-
selectin/ICAM-1 surfaces are indeed mediated by ICAM-1
interacting with the antibody present on microsphere surface.
DISCUSSION
The role of endothelial selectin in ICAM-mediated ﬁrm
arrest and eventual transmigration of leukocytes in response
to inﬂammation is a major focus of research. The mechanism
of initial leukocyte tethering or rolling is well characterized,
and is believed to be important in bringing leukocyte within
the proximity necessary for integrin activation by chemo-
attractants such as platelet-activating factor (PAF) (Butcher,
1991; Lawrence and Springer, 1991; Springer, 1994). In
addition, selectins (molecules known to mediate rolling)
have been implicated in the direct activation of cell arrest,
independent of chemotactic signaling (Gopalan et al., 1997;
Evangelista et al., 1999; Simon et al., 2000). Unlike lym-
phocytes, in which chemokines directly involved in arrest
have been found that target lymphocytes to speciﬁc sites
(Campbell and Butcher, 2000), no chemokines has been
found in granulocytes, which has led to a focus on the novel
signal transduction mechanisms involved in the process of
granulocyte ﬁrm adhesion. Overlooked, however, is the role
that selectin physical chemistry plays in facilitating ﬁrm
adhesion, outside of its role as a direct activator of b2-
integrins. In this work, we attempted to begin to understand
the dynamics of a two-receptor system comprised of a weak
receptor, sLeX, and a stronger receptor, anti-ICAM-1, inter-
acting with their corresponding ligands, P-selectin and
ICAM-1, respectively. Our goal was to develop a two-
receptor system that allows us to elucidate basic scientiﬁc
principles in adhesion. Understanding these interactions will
afford us the fundamental understanding necessary to
explore the role of selectin-ligand interactions (rolling) in
facilitating the transition from rolling to ﬁrm adhesion in
leukocytes. Our work utilizes a cell-free system that is
comprised of a parallel plate ﬂow chamber with a P-selectin/
ICAM-1 coated surface making the bottom part of the
chamber. We perfused over this P-selectin/ICAM-1 coated
surface polystyrene microspheres whose surfaces have been
modiﬁed with P-selectin ligand, sLeX, and a monoclonal
antibody against ICAM-1 via avidin-biotin chemistry.
Similar cell-free systems with microspheres coated with
selectin ligand, such as sLeX and PSGL-1, interacting with
selectin surfaces in parallel ﬂow chambers have been
successfully used to identify the role of selectin-ligand phy-
sical chemistry in supporting rolling interactions (Brunk and
Hammer, 1997; Greenberg et al., 2000; Rodgers et al., 2000).
Using our cell-free assay, we show that microspheres
coated with sLeX and aICAM-1 will roll and bind ﬁrmly to
P-selectin/ICAM-1 surfaces under ﬂow. We show that mi-
crosphere rolling and ﬁrm adhesion is dependent on the wall
shear stress within the ﬂow chamber. As wall shear stress
increases, the number of microspheres able to bind ﬁrmly
with P-selectin/ICAM-1 surfaces diminishes, resulting in a
decrease in the number of ﬁrmly adherent beads. Most
interestingly, we ﬁnd that ﬁrm adhesion of sLeX/aICAM-1
beads on P-selectin/ICAM-1 surfaces is dependent on sLeX/
aICAM-1 bead site density ratio as well as the substrate
surface density ratio of P-selectin/ICAM-1.
There are several distinct lines of evidence that suggest
selectin-mediated rolling can facilitate the transition to ﬁrm
adhesion presented in this article. They are:
1. As illustrated in Fig. 6 B, beads bearing combinations of
aICAM-1 and sLeX, at certain ratios, display equivalent
levels of ﬁrm adhesion to beads with only aICAM-1,
although beads with only aICAM-1 have a higher density
of aICAM-1 as shown in Table 1 and plotted in Fig. 6 B.
2. As illustrated in Fig. 7, the maximal level of ﬁrm binding
of 50:50 sLeX/aICAM-1 coated beads occurs on sub-
strates with 80% ICAM-1 and 20% P-selectin, not when
the surfaces have purely ICAM-1.
3. As illustrated in Fig. 8, there is a signiﬁcant increase in
ﬁrm binding of beads bearing the functional selectin
ligand, sLeX, in combination with aICAM-1, compared
to the beads bearing the nonfunctional ligand, LeX, with
aICAM-1 at the same surface densities of aICAM-1. If
rolling had no effect on ﬁrm adhesion, the extent of ﬁrm
adhesion should be the same.
Furthermore, the results of this article suggest there are
regimes in which each of the molecules can control binding.
In the P-selectin controlled regime, there is little ﬁrm
adhesion; increasing P-selectin density or P-selectin-ligand
interactions decreases the rolling velocity. In the ICAM-1
controlled regime, antibody/ICAM-1 interactions dominates,
more ﬁrm adhesion is seen, and increasing P-selectin den-
sities have little effect on the extent of ﬁrm adhesion and can
actually increase rolling velocity. In between these regimes,
P-selectin density plays a critical role in switching adhesion
from a rolling phenotype to a ﬁrm adhesion phenotype, and
greatly facilities the transition to ﬁrm adhesion. We also
showed that under the right conditions, combinations of the
two molecules can maintain stable rolling at a constant veloc-
ity across a wide range of concentrations.
The results of this article correspond well to the theoretical
results calculated and published recently by our laboratory
(Bhatia et al., 2003). In that article, we used Adhesive
Dynamics to calculate the dynamics of adhesion of leuko-
cytes to surfaces mediated by two adhesion molecules—a
selectin and an integrin. The validity of this model was
veriﬁed several ways; the most compelling was a systematic
comparison to experimental data on rolling in E-selectin or
b2-integrin knockout mice, in which the progressive change
in rolling velocity could be accurately recreated (Fig. 11 in
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Bhatia et al., 2003). This article anticipated many of the
principal effects elucidate here experimentally. For instance,
the state diagram for adhesion indicates that adding selectin
interactions for existing concentration of activated integrin
can lead to ﬁrm adhesion (Fig. 3 in Bhatia et al., 2003). Also,
progressive addition of a ﬁrm adhesion ligand can lead to the
progressive slowing of rolling, with increasing fraction of
time paused as shown experimentally in Fig. 10 here (Figs. 4
and 5 in Bhatia et al., 2003). Furthermore, subsequent
theoretical results show that a constant rolling velocity may
be achieved through a combination of different integrin and
selectin densities, as shown in Fig. 9 here (our unpublished
results). Thus the basic principles elucidated by experiment
were anticipated by theory, and the results of theory and
experiment correspond well.
The question is, to what extent does our cell-free system, in
which we explore the effect of P-selectin/ligand interactions
on the ﬁrm adhesion mediated by ICAM-1 interacting with
an antibody, in lieu of activated integrin or I-domain,
illustrate principles that apply to leukocytes?We trust readers
will recognize that reconstitution of an active integrin in
a well-designed orientation, density, and activation state is
not trivial given current technology, and a comprehensive
biophysical study would not be easily achieved given the
likely struggles such a molecule would engender. We do not
claim that our system is a mimetic of a leukocyte. Rather, we
believe our results suggest mechanisms that leukocytes may
use in securing ﬁrm binding.
However, we did measure the kinetics of binding of
aICAM-1, to compare to the kinetics of activated b2-integrin
binding to ICAM-1. The kinetics of the antibody to ICAM-1
used in our system is similar to that of activated LFA-1. The
measured on-rate (kon) for anti-ICAM-1 mAb, BBIG-I1, of
156,000 M1s1 is on the same order of magnitude as that of
puriﬁed I-domain in the locked open position (107,000
M1s1) and that of activated aLb2 integrin (224,000
M1s1) (Shimaoka et al., 2002). The off-rate of the
antibody (1.13 3 104 s1) from ICAM-1 is two orders of
magnitude lower than that of LFA-1 (2.983 102 s1) in its
active state. The surprising close correspondence of the on-
rate of the BBIG-I1 antibody with ICAM-1, and much lower
off-rate, leads to the following interpretations of the results.
First a lower off-rate should mean aICAM-1/ICAM-1
interactions are stronger, and better able to support ﬁrm
adhesion than activated integrin (Chang et al., 2000).
However, the value of having a lower off-rate than integrin
is questionable, since the activated b2-integrin’s off-rate
is already two orders of magnitude lower than that of
P-selectin/PSGL-1 interactions (Alon et al., 1995). Therefore,
aside from some details in the dynamics of rolling conveyed
by the lower off-rate, the ability to secure ﬁrm adhesion of
the antibody should be similar to that of an activated integrin.
Also, the ability of aICAM-1/ICAM-1 interactions to
support (stabilize) some extent of rolling is consistent with
that seen with the integrin I-domain or puriﬁed LFA-1 (Salas
et al., 2002), which have also been shown to support rolling.
Thus, the antibody functions like integrin—it can support
ﬁrm adhesion at high densities, yet at lower densities, it
stabilizes rolling just like b2-integrins. Second, the on-rate of
the antibody is similar to that of b2-integrins, and therefore
the ability of the antibody to capture beads (i.e., the extent
of ﬁrm adhesion) should also be similar. Thus, we expect
the synergy between selectin and antibody to ultimately be
similar to that between selectin and integrin, although we
fully recognize and look forward to testing these principles in
leukocytes or with beads bearing physiological ligands.
A comment on the use of sLeX as a ligand for P-selectin
is warranted. Rodgers and co-workers showed that sLeX is
a fully functional P-selectin ligand (Rodgers et al., 2000).
Similarly, Brunk and co-workers showed that sLeX and
isomer, sLea, are functional ligands for E-selectin (Brunk and
Hammer, 1997). Also, Somers and co-workers showed that
a desulfated form of PSGL-1, which bears sLeX, is functional
as a P-selectin ligand and structural studies show that an
sLeX residue ligates with P-selectin in the desulfated form
(Somers et al., 2000). Rodgers et al. also showed in a cell-
free system that desulfated PSGL-1 bearing sLeX supported
rolling in a cell-free system (Rodgers et al., 2000). Thus,
with the goal of creating a two-molecule system to identify
the interplay between two molecules on beads, the use of
sLeX as a selectin ligand seems reasonable. Using this
carbohydrate also allowed for a clean comparison with LeX
that would not be possible with PSGL-1.
Given the results of this article, and the possibility that the
principle illustrated herein may be at play in the transition of
leukocyte rolling to ﬁrm adhesion, we suggest the following
similarities to the adhesion of leukocytes. For one, the
dependency of the ﬁrm adhesion of our two-receptor
microspheres on the wall shear stress within the ﬂow
chamber is similar to what has been previously measured for
leukocyte adhesion by Simon and co-workers, where they
found that the efﬁciency of integrin dependent adhesion of
leukocytes on stimulated, cultured endothelial cells de-
creases from a maximum as applied shear increases (Simon
et al., 2000). Furthermore, although it has been shown that
ICAMs can facilitate some ﬁrm adhesion of leukocytes in the
absence of selectin-ligand interactions (Gopalan et al., 1997;
Simon et al., 2000), our results clearly suggest the role
selectin-ligand can have in facilitating ﬁrm adhesion
mediated by a high afﬁnity ligand to ICAM-1 as highlighted
in Fig. 6. Finally, rolling velocity data obtained for sLeX/
aICAM-1 microspheres interacting with P-selectin/ICAM-1
surfaces show that ICAM-1/antibody interactions slow
rolling as shown in Figs. 9 and 10. This observation is
similar to what has previously been reported with b2-integrin
(CD18) deﬁcient mice, where the velocities at which
leukocytes roll in these mice were observed to be higher
than the wild-type suggesting synergistic roles of selectin
and ICAMs in leukocyte rolling adhesion (Kunkel et al.,
1996; Jung et al., 1998). This observation also suggests that
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the transition from rolling to ﬁrm adhesion is a gradual
process, where the initial interaction of intercellular adhesion
molecules with their ligands serves to stabilize selectin-
mediated adhesion to achieve optimum cell interaction with
the endothelium. These interactions then eventually lead to
ﬁrm arrest followed by cell transmigration. Also, the pause
times are suspected of having critical effects on downstream
signaling, so the ratio of selectin/ICAMs likely has a major
effect on the ability of the leukocyte to see and harvest
information from endothelium during rolling adhesion.
Thus, the biophysical principles elucidated here may very
well be involved in leukocyte adhesion.
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